CHARGE-AF Score May Be Better Predictor of Atrial Fibrillation Risk

MedicalResearch.com Interview with:

Ingrid Elisabeth Christophersen MD PhD Postdoctoral research fellow Cardiovascular Research Center (CVRC) Massachusetts General Hospital

Dr. Ingrid Elisabeth-Christophersen

Ingrid Elisabeth Christophersen MD PhD
Postdoctoral research fellow
Cardiovascular Research Center (CVRC)
Massachusetts General Hospital

MedicalResearch.com: What is the background for this study? What are the main findings?

Dr. Christophersen: Several recent studies have utilized the CHA2DS2-VASc risk score to predict risk of atrial fibrillation (AF). However, the CHA2DS2-VASc was developed for prediction of stroke risk in patients with AF and has not been validated for prediction of AF risk. We have evaluated how well the CHA2DS2-VASc performed at predicting risk of AF compared with the most validated clinical risk score for AF – the CHARGE-AF risk score – in the Framingham Heart Study. We showed that the CHARGE-AF risk score performed better at predicting risk of AF than the CHA2DS2-VASc.

MedicalResearch.com: What should readers take away from your report?

Dr. Christophersen:  We aimed at identifying the most robust risk score for  atrial fibrillation, which can be used as a tool for primary and secondary prevention of AF, including prevention of serious complications, such as stroke. This study suggests that the CHARGE-AF risk score could be such a tool; however, further studies are needed to confirm our results.

MedicalResearch.com: What recommendations do you have for future research as a result of this study?

Dr. Christophersen:  Our findings should be validated in a larger population and in populations of other ancestries to improve generalizability. Further, there is a need for studies evaluating preventive measures against AF, using a robust clinical risk score for  atrial fibrillation to identify individuals at increased risk for AF.

MedicalResearch.com: Thank you for your contribution to the MedicalResearch.com community.

Citation:
A comparison of the CHARGE-AF and the CHA2DS2-VASc risk scores for prediction of atrial fibrillation in the Framingham Heart Study
Christophersen, Ingrid E. et al.
American Heart Journal , May 17, 2016
DOI: http://dx.doi.org/10.1016/j.ahj.2016.05.004

Note: Content is Not intended as medical advice. Please consult your health care provider regarding your specific medical condition and questions.
More Medical Research Interviews on MedicalResearch.com

No Comments

Post A Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.